4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Tremor after long term lithium treatment; is it cortical myoclonus?

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Tremor is a common side effect of treatment with lithium. Its characteristics can vary and when less rhythmical, distinction from myoclonus can be difficult.

          Methods

          We identified 8 patients on long-term treatment with lithium that developed upper limb tremor. All patients were assessed clinically and electrophysiologically, with jerk-locked averaging (JLA) and cross-correlation (CC) analysis, and five of them underwent brain MRI examination including spectroscopy (MRS) of the cerebellum.

          Results

          Seven patients (6 female) had action and postural myoclonus and one a regular postural and kinetic tremor that persisted at rest. Mean age at presentation was 58 years (range 42–77) after lengthy exposure to lithium (range 7–40 years). During routine monitoring all patients had lithium levels within the recommended therapeutic range (0.4-1 mmol/l). There was clinical and/or radiological evidence (on cerebellar MRS) of cerebellar dysfunction in 6 patients. JLA and/or CC suggested a cortical generator of the myoclonus in seven patients. All seven were on antidepressants and three additionally on neuroleptics, four of them had gluten sensitivity and two reported alcohol abuse.

          Conclusions

          A synergistic effect of different factors appears to be contributing to the development of cortical myoclonus after chronic exposure to lithium. We hypothesise that the cerebellum is involved in the generation of cortical myoclonus in these cases and factors aetiologically linked to cerebellar pathology like gluten sensitivity and alcohol abuse may play a role in the development of myoclonus. Despite the very limited evidence in the literature, lithium induced cortical myoclonus may not be so rare.

          Electronic supplementary material

          The online version of this article (10.1186/s40673-019-0100-y) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references51

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Lithium side effects and toxicity: prevalence and management strategies

          Despite its virtually universal acceptance as the gold standard in treating bipolar disorder, prescription rates for lithium have been decreasing recently. Although this observation is multifactorial, one obvious potential contributor is the side effect and toxicity burden associated with lithium. Additionally, side effect concerns assuredly play some role in lithium nonadherence. This paper summarizes the knowledge base on side effects and toxicity and suggests optimal management of these problems. Thirst and excessive urination, nausea and diarrhea and tremor are rather common side effects that are typically no more than annoying even though they are rather prevalent. A simple set of management strategies that involve the timing of the lithium dose, minimizing lithium levels within the therapeutic range and, in some situations, the prescription of side effect antidotes will minimize the side effect burden for patients. In contrast, weight gain and cognitive impairment from lithium tend to be more distressing to patients, more difficult to manage and more likely to be associated with lithium nonadherence. Lithium has adverse effects on the kidneys, thyroid gland and parathyroid glands, necessitating monitoring of these organ functions through periodic blood tests. In most cases, lithium-associated renal effects are relatively mild. A small but measurable percentage of lithium-treated patients will show progressive renal impairment. Infrequently, lithium will need to be discontinued because of the progressive renal insufficiency. Lithium-induced hypothyroidism is relatively common but easily diagnosed and treated. Hyperparathyroidism from lithium is a relatively more recently recognized phenomenon.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The pathophysiology of tremor.

            Tremor is defined as rhythmic oscillatory activity of body parts. Four physiological basic mechanisms for such oscillatory activity have been described: mechanical oscillations; oscillations based on reflexes; oscillations due to central neuronal pacemakers; and oscillations because of disturbed feedforward or feedback loops. New methodological approaches with animal models, positron emission tomography, and mathematical analysis of electromyographic and electroencephalographic signals have provided new insights into the mechanisms underlying specific forms of tremor. Physiological tremor is due to mechanical and central components. Psychogenic tremor is considered to depend on a clonus mechanism and is thus believed to be mediated by reflex mechanisms. Symptomatic palatal tremor is most likely due to rhythmic activity of the inferior olive, and there is much evidence that essential tremor is also generated within the olivocerebellar circuits. Orthostatic tremor is likely to originate in hitherto unidentified brainstem nuclei. Rest tremor of Parkinson's disease is probably generated in the basal ganglia loop, and dystonic tremor may also originate within the basal ganglia. Cerebellar tremor is at least in part caused by a disturbance of the cerebellar feedforward control of voluntary movements, and Holmes' tremor is due to the combination of the mechanisms producing parkinsonian and cerebellar tremor. Neuropathic tremor is believed to be caused by abnormally functioning reflex pathways and a wide variety of causes underlies toxic and drug-induced tremors. The understanding of the pathophysiology of tremor has made significant progress but many hypotheses are not yet based on sufficient data. Modern neurology needs to develop and test such hypotheses, because this is the only way to develop rational medical and surgical therapies. Copyright 2001 John Wiley & Sons, Inc.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Myoclonus: current concepts and recent advances.

              Myoclonus presents as a sudden brief jerk caused by involuntary muscle activity. An organisational framework is crucial for determining the medical significance of the myoclonus as well as for its treatment. Clinical presentations of myoclonus are divided into physiological, essential, epileptic, and symptomatic. Most causes of myoclonus are symptomatic and include posthypoxia, toxic-metabolic disorders, reactions to drugs, storage disease, and neurodegenerative disorders. The assessment of myoclonus includes an initial screening for those causes that are common or easily corrected. If needed, further testing may include clinical neurophysiological techniques, enzyme activities, tissue biopsy, and genetic testing. The motor cortex is the most commonly shown myoclonus source, but origins from subcortical areas, brainstem, spinal, and peripheral nervous system also occur. If treatment of the underlying disorder is not possible, treatment of symptoms is worthwhile, although limited by side-effects and a lack of controlled evidence.
                Bookmark

                Author and article information

                Contributors
                p.sarrigiannis@sheffield.ac.uk
                takiszis@gmail.com
                Zoe.Unwin@sth.nhs.uk
                d.blackburn@sheffield.ac.uk
                n.hoggard@sheffield.ac.uk
                yifan.zhao@cranfield.ac.uk
                S.Billings@sheffield.ac.uk
                Aijaz.Khan@sth.nhs.uk
                john.yianni@sth.nhs.uk
                m.hadjivassiliou@sheffield.ac.uk
                Journal
                Cerebellum Ataxias
                Cerebellum Ataxias
                Cerebellum & Ataxias
                BioMed Central (London )
                2053-8871
                22 May 2019
                22 May 2019
                2019
                : 6
                : 5
                Affiliations
                [1 ]ISNI 0000 0000 9422 8284, GRID grid.31410.37, Department of Clinical Neurophysiology, , Sheffield Teaching Hospitals NHS Foundation Trust, ; Royal Hallamshire Hospital, Floor N., Sheffield, UK
                [2 ]ISNI 0000 0000 9422 8284, GRID grid.31410.37, Department of Neurology, , Sheffield Teaching Hospitals NHS Foundation Trust, ; Sheffield, UK
                [3 ]ISNI 0000 0000 9422 8284, GRID grid.31410.37, Department of Neuroradiology, , Sheffield Teaching Hospitals NHS Foundation Trust, ; Sheffield, UK
                [4 ]ISNI 0000 0001 0679 2190, GRID grid.12026.37, Through-life Engineering Services Centre, , Cranfield University, ; Bedford, MK43 0AL UK
                [5 ]ISNI 0000 0004 1936 9262, GRID grid.11835.3e, Department of Automatic Control and Systems Engineering, , University of Sheffield, ; S1 3JD, Sheffield, UK
                [6 ]ISNI 0000 0000 9422 8284, GRID grid.31410.37, Department of Neurosurgery, , Sheffield Teaching Hospitals NHS Foundation Trust, ; Sheffield, UK
                Author information
                http://orcid.org/0000-0002-8380-8755
                Article
                100
                10.1186/s40673-019-0100-y
                6532190
                31143451
                c4cdd036-e777-4a02-bffe-e3bbb7d8eb59
                © The Author(s). 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 22 March 2019
                : 7 May 2019
                Categories
                Case Report
                Custom metadata
                © The Author(s) 2019

                lithium,cerebellar ataxia,cortical myoclonus,gluten sensitivity,jla,mrs

                Comments

                Comment on this article